Literature DB >> 7346234

Peptide mapping of collagen chains using CNBr cleavage of proteins within polyacrylamide gels.

G S Barsh, K E Peterson, P H Byers.   

Abstract

A peptide mapping technique is described which uses a two dimensional format to display CNBr peptides of collagen chains. Biosynthetically-labeled products from 250,000 cells are analyzed in each map by a rapid procedure which does not require preliminary purification steps. Proteins trapped within polyacrylamide gels are digested with CNBr under conditions where diffusion of radiolabeled peptides from gels is negligible, and the reaction products are recovered quantitatively by electroelution. Peptide maps of pro alpha chains, alpha chains, and TCA chains cleaved with mammalian collagenase are presented with the identification of specific fragments. This method is useful for the analysis of structural abnormalities in collagen proteins from patients with certain genetic disorders, examination of collagenous proteins produced by primary cultures which exhibit phenotypic switching, and identification of new collagen types.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7346234     DOI: 10.1016/s0174-173x(81)80035-0

Source DB:  PubMed          Journal:  Coll Relat Res        ISSN: 0174-173X


  18 in total

1.  A single base mutation in type I procollagen (COL1A1) that converts glycine alpha 1-541 to aspartate in a lethal variant of osteogenesis imperfecta: detection of the mutation with a carbodiimide reaction of DNA heteroduplexes and direct sequencing of products of the PCR.

Authors:  J P Zhuang; C D Constantinou; A Ganguly; D J Prockop
Journal:  Am J Hum Genet       Date:  1991-06       Impact factor: 11.025

2.  The molecular defect in a family with mild atypical osteogenesis imperfecta and extreme joint hypermobility: exon skipping caused by an 11-bp deletion from an intron in one COL1A2 allele.

Authors:  A C Nicholls; J Oliver; D V Renouf; D A Heath; F M Pope
Journal:  Hum Genet       Date:  1992-03       Impact factor: 4.132

3.  Perinatal lethal osteogenesis imperfecta (OI type II): a biochemically heterogeneous disorder usually due to new mutations in the genes for type I collagen.

Authors:  P H Byers; P Tsipouras; J F Bonadio; B J Starman; R C Schwartz
Journal:  Am J Hum Genet       Date:  1988-02       Impact factor: 11.025

4.  Underhydroxylated minor cartilage collagen precursors cannot form stable triple helices.

Authors:  C C Clark; C F Richards
Journal:  Biochem J       Date:  1988-02-15       Impact factor: 3.857

5.  Osteogenesis imperfecta type IV. Biochemical confirmation of genetic linkage to the pro alpha 2(I) gene of type I collagen.

Authors:  R J Wenstrup; P Tsipouras; P H Byers
Journal:  J Clin Invest       Date:  1986-12       Impact factor: 14.808

6.  A lethal variant of osteogenesis imperfecta has a single base mutation that substitutes cysteine for glycine 904 of the alpha 1(I) chain of type I procollagen. The asymptomatic mother has an unidentified mutation producing an overmodified and unstable type I procollagen.

Authors:  C D Constantinou; K B Nielsen; D J Prockop
Journal:  J Clin Invest       Date:  1989-02       Impact factor: 14.808

7.  Type II achondrogenesis-hypochondrogenesis: identification of abnormal type II collagen.

Authors:  M Godfrey; D W Hollister
Journal:  Am J Hum Genet       Date:  1988-12       Impact factor: 11.025

8.  Type I osteogenesis imperfecta: a nonfunctional allele for pro alpha 1 (I) chains of type I procollagen.

Authors:  G S Barsh; K E David; P H Byers
Journal:  Proc Natl Acad Sci U S A       Date:  1982-06       Impact factor: 11.205

9.  Abnormal alpha 2-chain in type I collagen from a patient with a form of osteogenesis imperfecta.

Authors:  P H Byers; J R Shapiro; D W Rowe; K E David; K A Holbrook
Journal:  J Clin Invest       Date:  1983-03       Impact factor: 14.808

10.  Phenotypic variability and abnormal type I collagen unstable at body temperature in a family with mild dominant osteogenesis imperfecta.

Authors:  R Tenni; P Biglino; K Dyne; A Rossi; M Filocamo; F Pendola; P Brunelli; P Buttitta; C Borrone; G Cetta
Journal:  J Inherit Metab Dis       Date:  1991       Impact factor: 4.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.